The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 26, 2002

Filed:

Nov. 16, 2000
Applicant:
Inventors:

Frantisek Zak, Brno, CZ;

Adolf Mistr, Tisnov, CZ;

Anna Poulova, Ivancice, CZ;

Milan Melka, Hradec Kralove, CZ;

Jaroslav Turanek, Jemnice, CZ;

Dana Zaluska, Dolni Loucky, CZ;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 4/740 ; A61K 3/324 ; C08B 3/716 ;
U.S. Cl.
CPC ...
A61K 4/740 ; A61K 3/324 ; C08B 3/716 ;
Abstract

A platinum complex of the general formula (I) wherein X represents a halogen atom and A represents a group —NH —R wherein R is a tricyclic hydrocarbon moiety containing 10 to 14 carbon atoms which may be optionally substituted on the tricyclic ring by one or two alkyl group(s) containing 1 to 4 carbon atoms, and, furthermore, an inclusion complex of the above platinum complex with beta- or gamma-cyclodextrin which may be optionally substituted by a hydroxyalkyl group of 1 to 6 carbon atoms. There are also disclosed a method for the preparation of the complex of the formula (I) based on bringing into reaction a solution of an akaline metal salt of amminetrihalogenoplatinate (1−) in a polar organic solvent or in water with a primary amine of formula R—NH , wherein R is a tricyclic hydrogen moiety containing 10 to 14 carbon atoms, which may be optionally substituted on the tricyclic ring by one or two alkyl group(s) each containing 1 to 4 carbon atoms, at the temperature in the range of 0 to 100° C., as well as a method for manufacture of the above inclusion complex. The both disclosed complexes may be used as such or as a part of pharmaceutical composition in a therapy of oncologic diseases.


Find Patent Forward Citations

Loading…